Rizwan Naeem

4.3k total citations · 1 hit paper
10 papers, 3.5k citations indexed

About

Rizwan Naeem is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Rizwan Naeem has authored 10 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Genetics. Recurrent topics in Rizwan Naeem's work include Glycosylation and Glycoproteins Research (2 papers), Chromosomal and Genetic Variations (2 papers) and Genomic variations and chromosomal abnormalities (2 papers). Rizwan Naeem is often cited by papers focused on Glycosylation and Glycoproteins Research (2 papers), Chromosomal and Genetic Variations (2 papers) and Genomic variations and chromosomal abnormalities (2 papers). Rizwan Naeem collaborates with scholars based in United States, France and Japan. Rizwan Naeem's co-authors include Dennis C. Sgroi, Fernando Arenzana‐Seisdedos, Thierry Delaunay, Andrea L. Richardson, Akira Orimo, Piyush B. Gupta, Vincent J. Carey, Robert A. Weinberg, Herbert C. Morse and Monica J. Justice and has published in prestigious journals such as Cell, Nature Biotechnology and Cancer Research.

In The Last Decade

Rizwan Naeem

9 papers receiving 3.4k citations

Hit Papers

Stromal Fibroblasts Present in Invasive Human Breast Carc... 2005 2026 2012 2019 2005 500 1000 1.5k 2.0k 2.5k

Peers

Rizwan Naeem
Natasha Y. Frank United States
Nancy Dumont United States
Farbod Shojaei United States
Agnieszka E. Gorska United States
Kaisa Lehti Finland
Robert W. Cho United States
Scott J. Dylla United States
Dalong Qian United States
Natasha Y. Frank United States
Rizwan Naeem
Citations per year, relative to Rizwan Naeem Rizwan Naeem (= 1×) peers Natasha Y. Frank

Countries citing papers authored by Rizwan Naeem

Since Specialization
Citations

This map shows the geographic impact of Rizwan Naeem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rizwan Naeem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rizwan Naeem more than expected).

Fields of papers citing papers by Rizwan Naeem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rizwan Naeem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rizwan Naeem. The network helps show where Rizwan Naeem may publish in the future.

Co-authorship network of co-authors of Rizwan Naeem

This figure shows the co-authorship network connecting the top 25 collaborators of Rizwan Naeem. A scholar is included among the top collaborators of Rizwan Naeem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rizwan Naeem. Rizwan Naeem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Naeem, Rizwan, Robert A. Krance, E. Shannon Neeley, et al.. (2009). Overexpression of ZNF342 by juxtaposition with MPO promoter/enhancer in the novel translocation t(17;19)(q23;q13.32) in pediatric acute myeloid leukemia and analysis of ZNF342 expression in leukemia. Genes Chromosomes and Cancer. 48(6). 480–489. 10 indexed citations
3.
Morse, Herbert C., et al.. (2007). Overexpression of Eg5 Causes Genomic Instability and Tumor Formation in Mice. Cancer Research. 67(21). 10138–10147. 119 indexed citations
4.
Naeem, Rizwan, et al.. (2007). A constitutional balanced t(3;8)(p14;q24.1) translocation results in disruption of the TRC8 gene and predisposition to clear cell renal cell carcinoma. Genes Chromosomes and Cancer. 46(9). 805–812. 27 indexed citations
5.
Sahoo, Trilochan, et al.. (2005). A patient with isochromosome 18q, radial-thumb aplasia, thrombocytopenia, and an unbalanced 10;18 chromosome translocation. American Journal of Medical Genetics Part A. 133A(1). 93–98. 7 indexed citations
6.
Orimo, Akira, Piyush B. Gupta, Dennis C. Sgroi, et al.. (2005). Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion. Cell. 121(3). 335–348. 2987 indexed citations breakdown →
7.
Yatsenko, Svetlana A., et al.. (2004). Attenuated phenotype in a child with trisomy for 1q due to unbalanced X;1 translocation [46,X,der(X),t(X;1)(q28;q32.1)]. American Journal of Medical Genetics Part A. 128A(1). 72–77. 9 indexed citations
8.
Duan, Zhenfeng, Yifei Duan, Diana E. Lamendola, et al.. (2003). Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicin-resistant human cancer cell lines.. PubMed. 9(7). 2778–85. 120 indexed citations
9.
Kuroiwa, Yoshimi, Poothappillai Kasinathan, Rizwan Naeem, et al.. (2002). Cloned transchromosomic calves producing human immunoglobulin. Nature Biotechnology. 20(9). 889–894. 181 indexed citations
10.
Bhargava, Rohit, et al.. (2001). Tyrosine kinase activation in breast carcinoma with correlation to HER-2/neu gene amplification and receptor overexpression. Human Pathology. 32(12). 1344–1350. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026